According to GlobalData, SHOCKWAVE S4 is one of 97 product lines sold in the US pta balloon catheters market; these product lines are sold by 17 different manufacturers. The average selling price for SHOCKWAVE S4 decreased in hospitals, decreased in health systems, and increased outside of hospital facilities in 2022. The price of the SHOCKWAVE S4 device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Shockwave Medical apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Shockwave Medical overview
Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of atherosclerotic cardiovascular disease. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology. It provides products such as M5 catheter, M5+ catheter, and S4 catheter for the treatment of peripheral artery disease and C2 catheter for the treatment of coronary artery diseases. Its treatment portfolio includes Coronary Artery Disease and atherectomy. The company provides treating peripheral artery disease which occurs primarily in the legs and vessels throughout the body. It operates in the US, the UK, Japan, Germany and France. Shockwave is headquartered in Santa Clara, California, the US.
For a complete picture of SHOCKWAVE S4, PTA Balloon Catheters pricing in the US, buy the report here.